Clinical trials
Lymphoma, Follicular trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 14 |
| 2024 | 9 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Active, not recruiting | 23 |
| Recruiting | 20 |
| Terminated | 19 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Novartis Pharmaceuticals | 6 |
| Janssen Research & Development, LLC | 5 |
| Pfizer | 5 |
| Regeneron Pharmaceuticals | 5 |
| AstraZeneca | 4 |
| AbbVie | 3 |
| BeOne Medicines | 3 |
| Epizyme, Inc. | 3 |
| Genmab | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 105 |
| Lymphoma, Large B-Cell, Diffuse | 31 |
| Lymphoma, Non-Hodgkin | 30 |
| Lymphoma, B-Cell, Marginal Zone | 27 |
| Lymphoma, Mantle-Cell | 23 |
| Lymphoma | 19 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Lymphoma, B-Cell | 14 |
| Recurrence | 11 |
| Waldenstrom Macroglobulinemia | 11 |
Trials
Showing 51 to 75 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.